More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumor cells, with less need for chemotherapy, following results of multiple clinical trials reported for the first time in late-breaking presentations at the ESMO Congress 2023.
retrieved 18 October 2023 from https://medicalxpress.com/news/2023-10-experimental-drugs-lung-cancer-treatment.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Apr 16, 2023Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
New treatment options offer hope for patients with non-small cell lung cancerMore people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumour cells, with less need for chemotherapy, following results of multiple landmark clinical trials reported for the first time in late-breaking presentations at the ESMO Congress 2023 (1-7).
Consulte Mais informação »
Formafantasma and Rubelli relaunch experimental textile brand KiefferRosa Bertoli was born in Udine, Italy, and now lives in London. Since 2014, she has been the Design Editor of Wallpaper*, where she oversees design content for the print and online editions, as well as special editorial projects. Through her role at Wallpaper*, she has written extensively about all areas of design.
Consulte Mais informação »
Treatment for alcohol use disorder improves quality of life in men and women aged 60+, study findsAdults aged 60 and older reported better overall health and quality of life after treatment for their alcohol use disorder, according to a new study published in Alcohol: Clinical and Experimental Research.
Consulte Mais informação »
Late-breaking studies could change the treatment landscape for women with gynecological cancersResults from highly anticipated phase 3 clinical trials in gynecological cancers with, among others, new data that cover the entire spectrum of managing patients with cervical cancer, will be presented at the ESMO Congress 2023 in Madrid, Spain.
Consulte Mais informação »
New specimen collection system enhances assisted reproductive technologiesConsidered an experimental procedure during the late 1970s when it made headlines with each birth it produced, in vitro fertilization (IVF) has helped many couples overcome infertility issues for more than four decades. In several nations, IVF is responsible for up to 3% of the babies born.
Consulte Mais informação »
Study reveals previously unappreciated role for innate immune cells in early stages of TB infectionA new study from the University of Pittsburgh Center for Vaccine Research published today in the Journal of Experimental Medicine describes a previously unappreciated role for a class of immune cells in the early stages of tuberculosis (TB) infection.
Consulte Mais informação »